BIOA
BioAge Labs, IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$738.36M
P/E Ratio
—
EPS
$-2.40
Beta
—
52W High
$24.00
52W Low
$3.79
50-Day MA
$17.67
200-Day MA
$12.85
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About BioAge Labs, Inc
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United States and Canada. The company is headquartered in Montreal, Canada.
Fundamentals
| Revenue (TTM) | $10.32M |
| Gross Profit (TTM) | $-72.95M |
| EBITDA | $-101.47M |
| Operating Margin | -915.00% |
| Return on Equity | -26.00% |
| Return on Assets | -17.20% |
| Revenue/Share (TTM) | $0.27 |
| Book Value | $8.54 |
| Price-to-Book | 1.95 |
| Price-to-Sales (TTM) | 71.57 |
| EV/Revenue | 34.82 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 91.00% |
| Shares Outstanding | $44.45M |
| Float | $33.69M |
| % Insiders | 2.44% |
| % Institutions | 81.47% |
Historical Volatility
HV 10-Day
94.31%
HV 20-Day
81.26%
HV 30-Day
77.18%
HV 60-Day
85.09%
HV Rank
61.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($51.43 target)
2
Strong Buy3
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026